C

CGEM

CGEM

UnknownUnknown

Company information not available. Track real-time insider trading activity, SEC Form 4 filings, and executive stock transactions.

Insider Sentiment
Based on recent trading activity
0%Bearish
Buy/Sell Ratio81% buys
BearishBullish
CGEM Live QuoteReal-time
$8.89
$6.03(-40.42%)1M
Day Range$8.80 – $9.43
Open$8.84
Previous Close$9.07
Volume1.01M
Key Financials & Valuation
Fundamental balance sheet & market metrics
HEALTHCARE
Market Cap$579.10M
P/E Ratio (TTM)24.5
Forward P/E6.7
EPS (TTM)$-3.09
Price to Book2.1
Dividend Yield0.65%
Beta (Volatility)-0.06
IndustryBIOTECHNOLOGY
52-Week RangeCurrent: $8.89 (3%)
Low: $8.47High: $23.19
Wall Street Consensus
Sell
Analyst Rating
2.2/ 5.0
Target Price
$34.70-76.9% upside

Insider Buys

3

$13.32M

Insider Sales

35

$3.11M

Total Volume

$16.43M

63 transactions

Net Activity

+$10.21M

Net buying

Proprietary Ratings
Calculated from Form 4 transactions
70CONFIDENCE

Sentiment Rating

Moderate Accumulation

CEO Conviction Index

Liquidating / Profit Taking

Key Drivers

  • •Strong buying bias: purchases represent 81% of total transaction value.
  • •CEO selling activity detected. Often driven by option expiration or diversification plans.
  • •Ultra-high accumulation: total purchase value exceeds $10M.
Score Methodology

The Insider Confidence Score (1-100) measures executive conviction. Starting from a neutral 50, it adjusts based on:

  • +15Strong Buy Ratio: Purchases > 70% of volume (or up to -15 for heavy sales).
  • +20Cluster Buying: ≥3 unique insiders buying within a 30-day window.
  • +15CEO Buying: CEO committing own capital shows high conviction.
  • +10CFO Buying: CFO purchasing shares shows financial alignment.
Top Insiders
Most active traders
M
1

Multiple Insiders

S - Sale+OE Insiders

0 buys25 sells

$29442.36B total

L
2

Lynx1 Capital Management LP

10%

3 buys0 sells

$13.32M total

M
3

Michaelson Jennifer

Chief Scientific Officer

0 buys19 sells

$1.84M total

A
4

Ahmed Nadim

Pres, CEO

0 buys5 sells

$725K total

J
5

Jones Jeffrey Alan

Chief Medical Officer

0 buys5 sells

$274K total

Trading History
CGEM insider transactions from SEC Form 4 filings
DateInsiderTypeSharesPriceValueFiling

Nov 5, 2026

2 weeks ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell4.0K$12.36$49K

Sep 8, 2026

2 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell8.0K$21.57$173K

Sep 8, 2026

2 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell158.8K$-8000.00$0

Aug 13, 2026

3 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell162.8K$-30000.00$0

Aug 13, 2026

3 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell30.0K$20.26$608K

Jul 6, 2026

4 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell162.8K$-8000.00$0

Jul 6, 2026

4 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell8.0K$17.82$143K

May 5, 2026

6 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell166.8K$-8000.00$0

May 5, 2026

6 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell8.0K$14.62$117K

Mar 5, 2026

8 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell8.0K$15.68$125K

Mar 5, 2026

8 months ago

Multiple Insiders

S - Sale+OE Insiders

Insider
Sell170.8K$-8000.00$0

Feb 25, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell174.8K$-1780.00$0

Feb 25, 2026

8 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell1.8K$14.14$25K

Feb 23, 2026

9 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell5.4K$14.31$77K

Feb 23, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell176.6K$-5353.00$0

Feb 24, 2026

8 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell390.8K$-13515.00$0

Feb 24, 2026

8 months ago

Sumer Jacquelyn L

GC

General Counsel
Sell3.6K$14.47$52K

Feb 24, 2026

8 months ago

Jones Jeffrey Alan

Chief Medical Officer

C-Level
Sell4.6K$14.47$66K

Feb 24, 2026

8 months ago

Ahmed Nadim

Pres, CEO

CEO
Sell13.5K$14.47$196K

Feb 20, 2026

9 months ago

Sumer Jacquelyn L

GC

General Counsel
Sell3.7K$13.62$51K

Feb 20, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell164.6K$-4982.00$0

Feb 20, 2026

9 months ago

Jones Jeffrey Alan

Chief Medical Officer

C-Level
Sell5.0K$13.62$68K

Feb 20, 2026

9 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell11.7K$14.08$165K

Feb 20, 2026

9 months ago

Ahmed Nadim

Pres, CEO

CEO
Sell16.4K$13.62$223K

Feb 20, 2026

9 months ago

Fenton Mary Kay

CFO

CFO
Sell4.4K$13.62$60K

Feb 12, 2026

9 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell416$12.03$5K

Feb 12, 2026

9 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell128.2K$-416.00$0

Jan 22, 2026

10 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell128.6K$-4000.00$0

Jan 22, 2026

10 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell4.0K$12.30$49K

Dec 23, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell420.7K$-9922.00$0

Dec 23, 2025

11 months ago

Ahmed Nadim

Pres, CEO

CEO
Sell9.9K$10.01$99K

Dec 19, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell132.6K$-1345.00$0

Dec 19, 2025

11 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell1.3K$10.01$13K

Dec 18, 2025

11 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell2.9K$9.67$28K

Dec 18, 2025

11 months ago

Jones Jeffrey Alan

Chief Medical Officer

C-Level
Sell4.6K$9.67$45K

Dec 18, 2025

11 months ago

Sumer Jacquelyn L

GC

General Counsel
Sell3.5K$9.67$34K

Dec 18, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell135.4K$-3480.00$0

Dec 12, 2025

11 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell136.9K$-3143.00$0

Dec 12, 2025

11 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell3.1K$12.23$38K

Nov 24, 2025

12 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell4.0K$12.30$49K

Nov 24, 2025

12 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell138.0K$-4000.00$0

Oct 28, 2025

12 months ago

Lynx1 Capital Management LP

10%

10% Owner
Buy165.7K$8.40$1.39M

Oct 28, 2025

12 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell8.96M$165667.00$1484.96B

Oct 14, 2025

13 months ago

Lynx1 Capital Management LP

10%

10% Owner
Buy248.7K$8.46$2.10M

Oct 14, 2025

13 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell17.36M$248749.00$4318.77B

Oct 8, 2025

13 months ago

Multiple Insiders

P - Purchase Insiders

Insider
Sell16.19M$1459641.00$23638.63B

Oct 8, 2025

13 months ago

Lynx1 Capital Management LP

10%

10% Owner
Buy1.46M$6.73$9.83M

Feb 25, 2025

21 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell3.8K$8.53$32K

Feb 25, 2025

21 months ago

Jones Jeffrey Alan

Chief Medical Officer

C-Level
Sell4.9K$8.53$42K

Feb 25, 2025

21 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell174.2K$-4895.00$0

Feb 25, 2025

21 months ago

Sumer Jacquelyn L

GC

General Counsel
Sell3.8K$8.53$32K

Feb 25, 2025

21 months ago

Ahmed Nadim

Pres, CEO

CEO
Sell12.5K$8.53$107K

Jan 6, 2025

22 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell95.8K$-4000.00$0

Jan 6, 2025

22 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell4.0K$12.51$50K

Dec 24, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell263.1K$-8400.00$0

Dec 24, 2024

23 months ago

Ahmed Nadim

Pres, CEO

CEO
Sell8.4K$11.87$100K

Dec 18, 2024

23 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell4.7K$11.41$54K

Dec 18, 2024

23 months ago

Sumer Jacquelyn L

GC

General Counsel
Sell3.5K$11.41$40K

Dec 18, 2024

23 months ago

Jones Jeffrey Alan

Chief Medical Officer

C-Level
Sell4.6K$11.41$53K

Dec 18, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell99.8K$-4693.00$0

Dec 12, 2024

23 months ago

Michaelson Jennifer

Chief Scientific Officer

C-Level
Sell3.5K$12.52$44K

Dec 12, 2024

23 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell104.5K$-3489.00$0

Nov 5, 2024

24 months ago

Multiple Insiders

S - Sale Insiders

Insider
Sell107.9K$-8000.00$0
Sector & Industry Benchmarks
Unknown Comparison Overview
Industry Buy Conviction6%
CGEM Buy Conviction81%
Industry Rank#495 of 569
Volume Contribution0.1%
Total Industry Activity$16.52B

CGEM has an insider buy conviction of 81%, compared to the Unknown sector buy average of 6%. CGEM ranks #495 in insider activity out of 569 tracked companies in its industry.

Insider Trading Summary & Commentary
Automated executive transaction analysis for CGEM

Over the last 90 days, corporate insiders at CGEM (CGEM) engaged in a total of 63 transactions reported via SEC Form 4 filings. Among these, 3 were open-market purchases and 35 were sales. The total volume of insider trading reached $16.43M.

The net insider activity for CGEM shows a net buying bias of $10.21M. This activity represents a 81% buy ratio, suggesting that insiders are currently strongly bullish on the company's near-term outlook relative to recent history.

The most notable individual transaction was a Sale by Multiple Insiders (P - Purchase Insiders), who traded 16.19M shares valued at $23638.63B on Oct 8, 2025.

Live Market News & Developments
Aggregated real-time headlines for CGEM (CGEM)
6 updates

Cullinan Therapeutics, Inc. (CGEM) stock price, news, quote and history

Yahoo Finance Singapore2d ago

How Cullinan Oncology Inc. (CGEM) Affects Rotational Strategy Timing

Stock Traders Daily13h ago

Cullinan Therapeutics (Nasdaq:CGEM) - Stock Analysis

Simply Wall St3d ago

Cullinan Oncology LLC (CGEM) Stock Price, Chart & Analysis

debelegger.nl18d ago

$CGEM stock is down 21% today. Here's what we see in our data.

Quiver Quantitative16d ago

CGEM - Cullinan Therapeutics Inc Stock Price and Quote

Finviz178d ago

FAQs About CGEM Insider Trading

Answers to common questions regarding corporate filings and executive sentiment for CGEM.

Based on SEC Form 4 disclosures, the Insider Confidence Score for CGEM is currently 70/100, which reflects a moderate accumulation bias. This calculation accounts for a total of 3 purchases and 35 sales by company executives over the last 90 days.

The CEO Conviction Index for CGEM is rated as "Liquidating / Profit Taking". Executive buying is typically a strong vote of confidence as C-level leaders have the most intimate knowledge of their firm's prospects. Officer selling, on the other hand, is often routine and does not automatically signal operational weakness.

No. Insider tracking is a highly informative technical signal that indicates executive sentiment, but it should not be the sole basis for a transaction. Investors should combine this filing analysis with company financials, sector trends, and risk management criteria.